APSR2026-219

Yes
Late-Breaking
Submitted
Oral Presentation
AO07-004
 
 
https://storage.unitedwebnetwork.com/files/1285/1215970-46903-APSR26OralV5_433642.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

ZhaoJun Sheng * Tianjin Medical University General Hospital Department of Respiratory and Critical Care Medicine Tianjin China
XinJun Zhang - Aerospace Center Hospital Department of Respiratory and Critical Care Medicine Beijing China
JiaXin Li - Aerospace Center Hospital Department of Respiratory and Critical Care Medicine Beijing China
LiXia Dong - Tianjin Medical University General Hospital Department of Respiratory and Critical Care Medicine Tianjin China
LiXin Xie - Chinese PLA General Hospital College of Pulmonary & Critical Care Medicine Beijing China
Qi Wu - Tianjin Medical University General Hospital Department of Respiratory and Critical Care Medicine Tianjin China
 
 
 
 
 
 
 
 
 
Presenting Author Details
ZhaoJun
Sheng
sheng543951806@163.com
+8618210322827
31-40
China
Original Research
Study on the association between lower respiratory tract bacteriophage groups and pulmonary infectious diseases in different populations
Maximum 25 words
Abstract Content
Given the current challenges in treating pulmonary infectious diseases, bacteriophages have regained significant interest. This study investigates the composition and variations of the lower respiratory microbiome and bacteriophages among patients with distinct pulmonary infections, aiming to provide novel insights into phage-based therapies for respiratory infections.
We recruited three patient cohorts: lymphoma patients with bacterial pneumonia (ML-XJ), lymphoma patients with fungal pneumonia (specifically Pneumocystis jirovecii pneumonia, ML-PJP), and immunocompetent bronchiectasis patients with acute bacterial infections (H-BP). Clinical parameters (demographics, BMI, temperature, inflammatory markers) were compared across groups. Metagenomic and whole virome sequencing were performed on bronchoalveolar lavage fluid (BALF) samples.
Eight patients were included in each group (ML-PJP, ML-XJ, H-BP). Statistical analyses indicated no significant differences in baseline demographics (sex, age, BMI) or infection markers, ensuring comparable cohorts. Preliminary characterization revealed distinct microbial and bacteriophages community structures across groups. In microbiome analysis, PCoA and NMDS demonstrated significant compositional differences between H-BP vs. ML-PJP and H-BP vs. ML-XJ groups. Virome analysis via ANOSIM highlighted differences between H-BP vs. ML-PJP and H-BP vs. ML-XJ, but not between ML-PJP and ML-XJ. Alpha diversity was significantly reduced in lymphoma-associated groups (ML-PJP/ML-XJ) compared to H-BP, indicating diminished microbial diversity in immunocompromised hosts. LEfSe analysis of viral abundance further identified marked disparities between ML-PJP vs. H-BP and ML-XJ vs. H-BP groups.
Distinct ecological patterns in BALF microbiomes and bacteriophages were observed between lymphoma patients and immunocompetent bronchiectasis patients. Group-specific phage signatures suggest potential roles of bacteriophages in modulating host-pathogen dynamics. These findings deepen our understanding of tripartite interactions among phages, hosts, and pathogens, providing a theoretical foundation for phage therapy to target respiratory microbiota in pulmonary infections.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Bacteriophages, microbiomes, pulmonary infections
maximum 3 keywords and no abbreviations, separated by commas
Acknowledgments None Conflict of Interest / Disclosure The authors have no conflicts of interest to declare.
271